“Exploring Wearable Technology and Lean Mass Alterations in GLP-1 Agonists, Bariatric Surgery, and Testosterone Replacement Therapy: Commentary”, RPB, vol. 5, no. 1, Jan. 2025, doi: 10.53520/rdpb2025.107140.